Variant report
Variant | nsv1045683 |
---|---|
Chromosome Location | chr13:89306589-89347944 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLITRK5-7 | chr13:89324069-89324311 | NONHSAT034614 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187113832 | chr13:89307811-89307812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192697743 | chr13:89307845-89307846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150043519 | chr13:89307931-89307932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183021846 | chr13:89307958-89307959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563671058 | chr13:89307961-89307962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530910344 | chr13:89307996-89307997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17628712 | chr13:89308835-89308836 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs374863492 | chr13:89308872-89308873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537588892 | chr13:89308917-89308918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536244664 | chr13:89308918-89308919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548010809 | chr13:89308972-89308973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1326444 | chr13:89308999-89309000 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs141309897 | chr13:89309007-89309008 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557479686 | chr13:89309009-89309010 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570269868 | chr13:89309024-89309025 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537787972 | chr13:89309032-89309033 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556419106 | chr13:89309033-89309034 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575577857 | chr13:89309054-89309055 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114835465 | chr13:89309138-89309139 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372112020 | chr13:89309154-89309155 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7993257 | chr13:89309155-89309156 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs573397140 | chr13:89309197-89309198 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9583475 | chr13:89309210-89309211 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565489558 | chr13:89309227-89309228 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532745954 | chr13:89309231-89309232 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544627373 | chr13:89309247-89309248 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563177567 | chr13:89309254-89309255 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529693439 | chr13:89309285-89309286 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548187964 | chr13:89309290-89309291 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566082384 | chr13:89309343-89309344 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527393159 | chr13:89309350-89309351 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs74840510 | chr13:89309356-89309357 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112219724 | chr13:89309363-89309364 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570359254 | chr13:89309475-89309476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538021869 | chr13:89309477-89309478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556219206 | chr13:89309483-89309484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186096861 | chr13:89309505-89309506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189054786 | chr13:89309548-89309549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181916016 | chr13:89309592-89309593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs80245370 | chr13:89309599-89309600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs17628718 | chr13:89309600-89309601 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs35772222 | chr13:89324082-89324083 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs181071758 | chr13:89324120-89324121 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs186051721 | chr13:89324160-89324161 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs191994840 | chr13:89324200-89324201 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs541141182 | chr13:89324247-89324248 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs564200830 | chr13:89324249-89324250 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs370873499 | chr13:89324250-89324251 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs113244257 | chr13:89324254-89324255 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs185960746 | chr13:89324258-89324259 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:89307800-89308000 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
2 | chr13:89308800-89309000 | Enhancers | Hela-S3 | cervix |
3 | chr13:89309000-89309400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr13:89309000-89309400 | Flanking Active TSS | Hela-S3 | cervix |
5 | chr13:89309400-89309600 | Enhancers | Hela-S3 | cervix |
6 | chr13:89344400-89344600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr13:89344600-89345800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr13:89345800-89346400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr13:89346200-89346600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr13:89346400-89351200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |